Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomised single-centre study of intravenous lipid emulsions in extremely preterm infants
2008-000046-31Phase 4Completed
- Sponsor
- Sahlgrenska Center for Pediatric Ophthalmology Research
- Start
- Apr 2008
- Modality
- Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, randomised trial in retinopathy of prematurity (ROP) and preterm birth comparing SMOFlipid supplementation with Clinoleic (conventional lipid) treatment (2 arms). Primary endpoints: Serum fatty acid levels and Comparison of supplemented vs conventionally treated children. Started Apr 2008; status: completed.
02
Drugs
SMOFlipidClinoleic
03
Conditions
retinopathy of prematurity (ROP)preterm birth
Beyond the preview
Go deeper on 2008-000046-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-000046-31.